Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW856553 in active rheumatoid arthritis
NCT00393146Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of losmapimod in rheumatoid arthritis (RA), sponsored by GSK. Started Oct 2006; status: completed.
02
Drugs
losmapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00393146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393146.